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Available online 2 November 2016AbstractObjective: Sida cordifolia Linn. (Hindidkungyi; Sanskritdbala) is a shrub (family Malvaceae) grown all over India. In Ayurveda, the crushed
leaves of the plant is used for the treatment and dressing of wounds. Traditionally, root juice is also used to promote the healing of wounds.
This study was designed to evaluate the wound healing potential of hydrogel of methanolic extract of Sida cordifolia Linn. (MeOHSC) in
diabetic rats.
Methods: The methanolic extract in the form of hydrogel was applied topically for the management of wounds in fructose-fed streptozotocin-
induced diabetic rats. The % wound contraction, period of epithelialization, hydroxyproline content, and histopathological examination were
evaluated using the excision wound model, and tensile strength was measured using the incision wound model.
Results: The results showed that in both models, hydrogel of MeOHSC was found to have significant wound healing activity compared with
diabetic wound control in terms of % wound contraction ( p < 0.01), period of epithelialization ( p < 0.01), and hydroxyproline content
( p < 0.01) in the excision model, and tensile strength ( p < 0.01) in the incision model. The presence of collagen fibers and stronger growth of
epithelial cells were observed in hydrogel of MeOHSC than in the diabetic wound control group.
Conclusion: Our findings suggest that hydrogel of MeOHSC has a potential benefit in enhancing the wound healing process in diabetic condition.
This is possibly because of the presence of phenolic compounds and confirmation of gallic acid in the extracts.
Copyright © 2016, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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In the past few years, there has been an exponential growth
in the field of herbal medicine because of the natural origin
and fewer side effects of these resources. India is the largest
producer of medicinal herbs and is called as the botanical
garden of the world.1 Natural products are a source of syn-
thetic and traditional herbal medicine, and are still the primary
health care system.2 Herbal medicines are generally available* Corresponding author. Pharmacognosy and Phytochemistry Laboratory,
VNS Group of Institutions, Faculty of Pharmacy, VNS Campus, Neelbud,
Bhopal, 462044 Madhya Pradesh, India.
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ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).as a mixture of more than one plant constituent.3 Wound
healing is the process of regeneration of ruptured tissue after
injury to the skin or other soft tissue. Following injury to the
skin, the inflammatory responses begin, and cells below the
dermis begin to generate collagen (connective tissue) pro-
duction. The inflammatory responses involve phagocytosis of
foreign protein. Then, epithelial cells are regenerated and
differentiated into skin layers.4 In healthy individuals, the
acute wound healing process is maintained and completed
through the integration of multiple signals (in the form of
cytokines and chemokines) released by keratinocytes, fibro-
blasts, endothelial cells, macrophages, and platelets. During
wound-induced hypoxia, VEGF (vascular endothelial growth
factor) released by macrophages, fibroblasts, and epithelialby Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-
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nitric oxide synthase (eNOS) in the bone marrow, resulting in
an increase in NO levels, which triggers the mobilization of
bone marrow Endothelial Progenitor Cells (EPCs) to the cir-
culation. The chemokine SDF-1a promotes the homing of
these EPCs to the site of injury, where they participate in
neovasculogenesis. In diabetic patients, eNOS phosphoryla-
tion is impaired, which hinders the movement of EPCs from
bone marrow into circulation. It has also been shown that
SDF-1a expression is decreased in epithelial cells and myo-
fibroblasts in diabetic wounds, which prevents EPCs from
homing to wounds and therefore limits wound healing.5
Sida cordifolia Linn. (Hindidkungyi; Sanskritdbala), a
shrub belonging to family Malvaceae, is grown in tropical and
subtropical regions worldwide and all over India.6 In Ayur-
vedic practices, Sida cordifolia (S. cordifolia) has three com-
mon applications: Mashabaladi Kvatha, where the plant seeds
are mixed with other ingredients to relieve muscular pain;
Balataila, a process for the treatment of nervous system
complaints and stomach problems and as a cardiac tonic; and
the crushed leaves of the plant as an astringent for the treat-
ment and dressing of wounds or skin injuries. Traditionally,
root juice is also used to promote wound healing.7 This study
was designed to explore the wound healing activity of the
topically applied hydrogel of the methanolic extract of S.
cordifolia (MeOHSC) in diabetic rats.
2. Materials and methods2.1. Plant collectionThe selection of plant was based on traditional use such as
normal wound healing7 and hypoglycemic activities.8 S. cor-
difolia was collected from Vindhya Herbal Quality Testing and
Research Laboratory Bhopal (MP, India). S. cordifolia was
identified and authenticated by the botany section of Vindhya
Herbal Quality Testing and Research Laboratory, MFP-PARC,
Bhopal, MP, India (reference letter no. 62, dated 21/1/14), and
specimen herbarium was submitted. The aerial parts of S.
cordifolia were dried initially under shade and later preserved
in a tightly closed container.2.2. Preparation of plant extractThe powdered aerial part of S. cordifolia was defatted using
petroleum ether and later on extracted by methanol and
hydroalcohol. Methanolic extract was concentrated separately
under vacuum, and the resulting dried extract was kept in
refrigerator.2.3. Phytochemical screeningThe MeOHSC extract of the aerial parts was analysed for
the presence of phytoconstituents such as glycosides, flavo-
noids, carbohydrates, protein and amino acids, lipids, resins,
alkaloids etc.92.4. Determination of total phenolic contentThe concentration of phenolics in the plant extract was
determined using a spectrophotometric method. The
methanolic solution of the extract at a concentration of
1 mg/mL was used in the analysis. The reaction mixture
was prepared by mixing 0.5 mL methanolic solution of
the extract, 2.5 mL of 10% FolineCiocalteau reagent
dissolved in water, and 2.5 mL of 7.5% NaHCO3. Blank
was concomitantly prepared, containing 0.5 mL methanol,
2.5 mL 10% FolineCiocalteau reagent dissolved in water,
and 2.5 mL of 7.5% of NaHCO3. The samples were
thereafter incubated in a thermostat at 45C for 45 mi-
nutes. The absorbance was determined using a spectro-
photometer at lmax ¼ 765 nm.102.5. Determination of flavonoid concentrationThe content of flavonoids in the examined plant extract was
determined using the spectrophotometric method. The sample
contained 1 mL methanol solution of the extract at a con-
centration of 1 mg/mL and 1 mL of 2% AlCl3 solution dis-
solved in methanol. The samples were incubated for 1 hour at
room temperature. The absorbance was determined using a
spectrophotometer at lmax ¼ 415 nm.102.6. High-performance liquid chromatography analysisChromatographic analyses of samples were performed
using the Shimadzu high-performance liquid chromatog-
raphy (HPLC) system (Shimadzu Corp., Kyoto, Japan)
consisting of an LC-20AD pump and an SPD-M 20A
photodiode array detector. The C-18 column (dimension,
4.6 mm  150 mm; particle size, 5 mm) was used as the
stationary phase. HPLC-grade acetonitrile and water
(Thermo Fisher Scientific India Pvt. Ltd., Mumbai) were
used as the mobile phase at a ratio (water/acetonitrile/acetic
acid) of 90:10:0.01. The flow rate was 1 mL/min, the injec-
tion volume was 20 mL, and the temperature was set at 40C.
Detector wavelength (280 nm) was fixed on the basis of
UVeVisible spectrophotometer (Shimadzu Corp.) scan re-
ports of the MeOHSC.2.7. Sample preparation for HPLC analysisGallic acid (3,4,5-trihydroxybenzoic acid) was used as
standard to verify its presence and absence in the MeOHSC
extract. To prepare different concentrations of the standard
solution, 10 mg standard was weighed, dissolved, and made up
the volume with methanol in a 10-mL volumetric flask. Then,
0.2 mg/mL, 0.4 mg/mL, 0.6 mg/mL, and 0.8 mg/mL concen-
trations of standard solution were prepared. The same pro-
cedure was followed for preparing the 10 mg/mL sample
of MeOHSC extract, and samples were filtered through a
nylon filter with a pore size of 0.45 mm (Rankem, RFCL Ltd.,
New Delhi).
84 R.S. Pawar et al. / Journal of Acute Medicine 6 (2016) 82e892.8. Preparation of hydrogel formulationsTo prepare the hydrogel of MeOHSC, sodium metabisulfite,
methyl paraben sodium, and propyl paraben sodium were
dissolved in water. A gelling agent (Carbopol 934) was added,
and the mixture was stirred continuously until it became
swollen completely. Triethanolamine was slowly added to the
dispersion with continuous stirring that resulted in a stiff gel.
Next, MeOHSC (10%) was added, and stirring continued for
15 minutes. Volume was made up with water, and the mixture
was stirred continuously until a uniform gel was formed.11,122.9. Evaluation pH: 1gr of gel was weighed accurately and dissolved in
100 mL purified water. The pH of the dispersion was
measured using a digital pH meter.12
 Viscosity: the viscosity of the formulation was determined
as such without dilution by R/S CPS plus Rheometer
(Brookfield AMETEK, Massachusetts, USA) using spin-
dle 05 at 0.1 g.12
 Homogeneity: the formulation was tested for homogeneity
by visual inspection. It was also tested for physical
appearance and presence of any aggregates.12
 Test of skin irritancy: this test is performed by patch test.
The test substances were applied to an area of approxi-
mately 6 cm2 of skin and covered with a gauze patch. The
patch was loosely held in contact with skin by means of a
semiocclusive dressing for 4 hours and was then removed.
Observation was recorded 1 hour after the removal of the
patch. No visible reaction or erythema or intense erythema
with edema and vesicular erosion should occur; a good
hydrogel base shows no visible reaction.122.10. AnimalsHealthy adult albino rats (Wistar strain) of either sex with a
body weight between 150 g and 250 g were selected for the
study. The animals were kept under 12:12-hour day and night
schedules with the temperature set between 18C and 20C.
They were housed in large spacious hygienic cages during the
experimental period. Animals were allowed free access to water
and standard pellet diet up to the end of the study. The animal
study was conducted in VNS Group of Institutions, Faculty of
Pharmacy, Pharmacology Division, Bhopal (MP, India), with
due permission from the Institutional Animal Ethical Com-
mittee (CPCSEA protocol no. PH/IAEC/VNS/2K14/006).2.11. Experimental protocolThe animals were divided into three groups, with each
group containing six animals for excision and incision wound
models. In the excision wound model and incision wound
model, Group I was considered as normal wound control andtreated with only hydrogel base, Group II was denoted as
diabetic wound control and treated with only hydrogel base,
and Group III received topically hydrogel of MeOHSC. They
were applied daily, and the healing property was assessed in
terms of physical, biochemical, and histopathological studies.2.12. Induction of type 2 diabetesWistar albino rats were made diabetic by administering them
with 10% fructose solution and a single injection of streptozo-
tocin (STZ) prepared in citrate buffer (0.1M, pH 4.5), 40 mg/kg
(intraperitoneally), after overnight fasting. Blood glucose was
drawn from the tail vein, and glucose levels were determined
using a glucometer. Wistar albino rats having an elevated blood
glucose (>250 mg/dL) were selected for creation of excision
and incision wounds. Blood glucose levels were estimated at the
time of creation of the wounds and after the treatment.132.13. Excision diabetic wound modelAn excision wound model was done by cutting away 100
mm2 full thickness area on the depilated back of the rats. After
confirmation of diabetes, fasting blood glucose of >250 mg/dL
by glucometer on the 7th day wound induction was started.
The rats were anesthetized via administration of ketamine
(5 mg/kg body weight) and xylazine (50 mg/kg body weight).
The particular skin area was shaved 1 day prior to the
experiment. An excision wound was inflicted by cutting away
a 100-mm2 full thickness of skin from a predetermined shaved
area. Wounds were left undressed to the open environment.
In this model, % wound contraction, epithelialization period,
and hydroxyproline content were evaluated, and histopatho-
logical examination was done. The % wound contraction was
measured every 2nd day, and the period of epithelialization was
calculated on the complete removal of scar tissue. Hydroxy-
proline content was measured and histopathological examina-
tion was performed on Day 12 after wounding.142.14. Incision diabetic wound modelAll animals were anesthetized prior to wound creation, and
two full thickness paravertebral long incisions were made
through the skin at the distance of about 1 cm from the midline
on each side of the depilated back of rats. Both edges were
kept together and stitched with black silk surgical thread (no.
000), and a curved needle (no. 11) was used for stitching. The
sutures were removed on Day 3 after wounding, and breaking
strength was measured by continuous water flow techniques.42.15. Wound healing evaluation parameters
2.15.1. Percentage wound contraction and period of
epithelialization
Wound contraction in individual animals from the control
and treatment groups was measured for each 2-day interval
Table 1
Qualitative analysis of phytoconstituents of S. cordifolia.
Sample no. Phytoconstituents Identification test Methanolic extract
1. Carbohydrates Molish test þ
Barford test þ
Fehling's test 
Benedict test þþ
2. Proteins and amino acids Millons test þþ
Biuret test 
Ninhydrin test þþþ
3. Flavonoids Ammonia test þ
Magnesium turning þþ
Zinc turning þ
Vanillin HCl test þ
4. Glycosides Borntrager's test þþþ
LiebermaneBurchard test þþþ
5. Alkaloids Dragendorff's test þ
Mayer's test 
Hager's test 
Wagner's test 
6. Lipids Sudan IV þþ
7. Resins Solubility test þþþ
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wad expressed as percentage contraction.Table 2
%Wound contraction¼ Initial wound size specific day wound size
Initial wound size
 100Epithelialization period was monitored by noting the
number of days required for eschar to fall away, leaving no
raw wound behind.15
2.15.2. Hydroxyproline measurement
Wound tissues were analyzed on the 12th day for hy-
droxyproline content, a basic constituent of collagen. Tissues
were vacuum-dried to a constant weight and hydrolyzed in 6N
HCL at 130C for 3 hours in sealed tubes. The hydrolysate
was neutralized to pH 7, and then subjected to Chloramine-T
oxidation for 20 minutes. The reaction was terminated by the
addition of 0.4M perchloric acid, and developed color with
Ehlrich reagent at 60C was read at lmax ¼ 557 nm in UV
spectrophotometer (Shimadzu).16
2.15.3. Tensile strength
For measurement of tensile strength, the sutures of the
wound were removed on 3rd postwound day, and the skin
breaking strength was measured using the continuous water
flow technique described by Lee.17Content of total phenolics and flavonoids in plant extract of S. cordifolia.
Extract Total phenolics Total flavonoids2.16. Histopathological studies
(mg of GAE/g of extract) (mg of RE/g of extract)
Methanolic
extract
0.024 mg of GAE/g of extract 0.032 mg of RE/g of extract
GAE ¼ Gallic acid equivalent; RE ¼ Rutin equivalent.In histopathological studies, tissue samples were collected
on the 12th postwound day and fixed in 10% formalin solution
for 24 hours and dehydrated with a sequence of ethanolexyleneseries of solution. Then, they were filtered and embedded with
paraffin (40e60C), and microtome sections were taken at5-mm thickness. The sections were processed in alcohol-
exylene series and stained with hematoxylineeosin dye. The
histological samples were observed under a Digital microscope
(Labomed Inc., USA).182.17. Statistical analysisThe results were expressed as mean ± standard error mean.
The statistical significance was assessed using one-way anal-
ysis of variance followed by Dunnett's test.
3. Results3.1. Phytochemical studiesThis study revealed the presence of phytochemicals, which
are considered active medicinal chemical constituents, as
shown in Table 1. Important medicinal phytochemicals such as
Table 3
HPLC analysis of MeOHSC fractionate.
Sample no. Sample concentration
(MeOHSC) (mg/mL)
Area Retention time (min) Concentration of gallic acid in
MeOHSC extract (mg/10 mg extract)
1 10 127,351 4.833 74
HPLC ¼ high-performance liquid chromatography; MeOHSC ¼ methanolic extract of S. cordifolia.
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resins, and some traces of alkaloids were present in the
MeOHSC extract.3.2. Determination of phenolic compoundThe total phenolic content in the MeOHSC extract using
the FolineCiocalteau reagent is expressed in terms of gallic
acid equivalent or GAE (standard curve equation: y ¼ 0.0011x
 0.0867, r2 ¼ 0.996). The values obtained in the concentra-
tion of total phenols are expressed as mg of GAE/g of extract
(Table 2). The total phenolic content in the MeOHSC extract
was found to be 0.24 mg GAE/g.3.3. Determination of flavonoid contentThe concentration of flavonoids in the MeOHSC extract
was determined using the spectrophotometric method with
aluminum chloride. The content of flavonoids was expressedFigure 1. HPLC chromatograms of (A) standard gallic acid and (B) gallic acid i
MeOHSC ¼ methanolic extract of S. cordifolia.in terms of rutin equivalent (RE), mg of RE/g of extract (Table
2). The concentration of flavonoids in MeOHSC extract was
found to be 0.32 mg/g.3.4. HPLC analysisThe HPLC profile of MeOHSC extract is presented in
Table 3 (Figure 1). The standard gallic acid ( y ¼
60,409x þ 82,464, r2 ¼ 0.946) revealed one peak with a
retention time of 4.832 minutes. The methanolic extract
showed two peaks, in which Peak 1 is a minor peak with a
retention time of 4.833 minutes. It closely resembles that of
standard gallic acid peak, indicating that they are of similar
chemical structure, which may be responsible for the biolog-
ical activity. Meanwhile, Peak 2 is a major peak, which may
be another phytoconstituent or active medicinal constituent
present in the MeOHSC extract. This is possible owing to the
qualitative analysis of the MeOHSC extract.n hydrogel of MeOHSC. HPLC ¼ high-performance liquid chromatography;
Table 4
Evaluation of formulation (hydrogel).
Sample no. Hydrogel Parameter
pH Viscosity Pa.s Homogeneity Physical appearance
1 Methanolic extract 4.44 ± 0.05 2.980 Good Greenish black
Table 5
Effect of MeOHSC hydrogel on rate of % wound contraction in excision wound model.
Postwounding day Group I (normal control) Group II (diabetic control) Group III (diabetic wound control þ MeOHSC extract)
0 0 0 0
2nd 21.2 ± 4.1 13.25 ± 4 10 ± 0
4th 29.2 ± 4.3 22.5 ± 12 15 ± 5.7
6th 45.8 ± 10 38.7 ± 10 25 ± 5.7
8th 52.2 ± 11 41.25 ± 11 27.5 ± 9.5
10th 71.8 ± 12 56.5 ± 7 70 ± 8.1
12th 95 ± 1.0* 66.5 ± 7 97 ± 0.8
14th 100 ± 0* 74.6 ± 5 100 ± 0**
16th d 80 ± 8.1 d
18th d 85.9 ± 6.1 d
20th d 96.7 ± 0.9 d
Values represent mean ± standard error mean.
n ¼ 6 albino rats/group.
* p < 0.05, ** p < 0.01, comparison of Groups II and III.
MeOHSC ¼ methanolic extract of S. cordifolia.
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shown in Table 4. The hydrogel of MeOHSC was prepared
and subjected to evaluation of the parameters. The hydrogel
of MeOHSC was greenish black in color, uniform, and
nonirritant, and form the smooth gel. The pH of the formu-
lation was 4.44 ± 0.05, which was constant throughout the
study. The viscosity hydrogel of MeOHSC was found to be
2.980 Pa.s at 0.1 g and did not show variation during the
study.Figure 2. Effect of hydrogel of MeOHSC on rate of wound contraction in e3.6. Determination of percentage wound contractionThe percentage decrease in the wound surface area was
found to increase in a time-dependent manner in all groups
and is shown in Table 5 (Figure 2). In this study, the topical
application of hydrogel of MeOHSC in diabetic rats signifi-
cantly ( p < 0.01) enhanced the rate of % wound contraction
on the 12th day, and the normal wound control group showed
significantly ( p < 0.05) similar result on the 14th day as
compared with diabetic wound control group, which showed
poor wound healing on 20th postwound day.xcision wound model. MeOHSC ¼ methanolic extract of S. cordifolia.
Table 6
Effect of MeOHSC hydrogel on period of epithelialization, hydroxyproline content, and tensile strength in excision and incision wound models.
Groups/treatment Epithelialization period
(mean time of day)
Hydroxyproline
(mg/g tissue) on 12th day
after wounding
Tensile strength (g) on 3rd
day after wounding
Group Idnormal control (only Hydrogel base) 11 ± 0* 0.115 ± 0.005** 317.5 ± 1.5**
Group IIddiabetic control (only Hydrogel base) 13.3 ± 1.1 0.07 ± 0 271 ± 1
Group IIIddiabetic wound treated by Hydrogel of MeOHSC 9 ± 0** 0.31 ± 0.001** 351 ± 1**
Values represent mean ± standard error mean.
n ¼ 6 albino rats/group.
* p < 0.05, **p < 0.01, comparison of Groups II and III.
MeOHSC ¼ methanolic extract of S. cordifolia.
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of epithelialization was shown to exhibit extremely significant
( p < 0.01) results in the hydrogel of MeOHSC and also
showed significant ( p < 0.05) results in the normal wound
control group in comparison with a diabetic wound control
group, which showed poor epithelialization.3.8. Hydroxyproline measurementThe hydroxyproline content in wound tissue treated with
hydrogel of MeOHSC and normal wound control as well as
diabetic wound control are shown in Table 6. The hydroxy-
proline content in the hydrogel of MeOHSC-treated diabetic
rats, and the normal wound control group showed significantly
( p < 0.01) better result compared with the diabetic wound
control group.3.9. Tensile strengthThe hydrogel of MeOHSC was observed to exhibit signif-
icantly ( p < 0.01) good tensile strength, whereas the normal
wound control group showed significantly ( p < 0.01) similar
as well as good tensile strength when compared with the
diabetic wound control group, which seemed to exhibit poor
tensile strength (Table 6).3.10. Histopathological studyFigure 3. (A) Group I rats skin on Day 12 after wounding, which received
daily topical application of hydrogel base only. The figure shows normal
collagen fibers, fibroblasts cells, and new blood vesicles formation. (B) Group
II as diabetic wound control rat skin on Day 12 after wounding, which
received daily topical applications of hydrogel base only. The figure shows
ruptured blood vessels incomplete epithelial cell and less collagen content. (C)
Group III as diabetic wound treated with MeOHSC shows greater epithelial
cell growth with higher collagen content compared to diabetic control.
MeOHSC ¼ methanolic extract of S. cordifolia.The result of the histopathological examination is shown in
Figure 3. The hydrogel of MeOHSC-treated rats and the normal
wound control group showed stronger epithelial cell growth with
greater collagen content than the diabetic wound control group.
Fewer macrophages and fibroblasts were observed in the diabetic
control group when compared with the hydrogel of MeOHSC-
treated rats as well as the normal wound control group.
4. Discussion
Diabetic foot is the most common complication of diabetes,
even greater than retinopathy, nephropathy, heart attack, and
stroke combined. Infection frequently follows, and unless
there is aggressive intervention, amputation becomes the end
89R.S. Pawar et al. / Journal of Acute Medicine 6 (2016) 82e89point.19 The prevalence of diabetes among those older than 65
years of age was last estimated by the Centers for Disease
Control and Prevention using 2008 data from the National
Health Interview Survey. It is about 19.9% among those aged
65e74 years, and 17.1% among those older than 75 years of
age. These estimates are based on self-reports and are thought
to underestimate the true prevalence of one-third. In addition,
between 10% and 15% of those with diabetes can expect to
develop a foot ulcer at some point in their lives. Both foot
ulcer and amputation vary by geographic location.20 The aim
of this study is to evaluate the phytochemical and pharmaco-
logical effects of the methanolic extract of S. cordifolia for its
wound healing potential in diabetic rats.
The qualitative analysis showed the presence of various
phytoconstituents, which may participate individually or give
the synergetic effect in wound healing. The total phenolic
content (0.24 mg GA/g) and flavonoids content (0.32 mg RU/
g) found to be present in the extract may be responsible for the
biological activity of the hydrogel of MeOHSC. The HPLC
analysis of MeOHSC extract also confirms the presence of
gallic acid (74 mg/10 mg of extract), which is an active
medicinal constituent. Gallic acid, a polyphenol natural
product, is known to have antioxidant, anti-inflammatory,
antimicrobial, and radical scavenging activities.21 It is a food
component that is especially abundant in tea, and is an anti-
mutagenic, anticarcinogenic, and anti-inflammatory agent.22 It
also helps in the management of hyperglycemia, hyperlipid-
emia, and cardiac dysfunction associated with STZ-induced
type 1 diabetes in rats.23
The histopathological examination of hydrogel of
MeOHSC-treated rats and normal wound control group
showed greater epithelial cell growth with higher collagen
content than diabetic wound control. In the present study,
significantly ( p < 0.01) enhanced rate of % wound contrac-
tion, extremely significant ( p < 0.01) period of epithelializa-
tion, and significant ( p < 0.01) tensile strength seemed to
exhibit and confirmed the better wound healing activity of the
hydrogel of MeOHSC in diabetic rats.
5. Conclusion
In our study, we observed excellent results in treating dia-
betic wounds using the hydrogel of MeOHSC. However, we
continue to conduct further studies to assess the effect of
hydrogel of MeOHSC on various phases of wound healing,
including granulation, collagenation, and epithelialization at
the cellular and molecular levels.
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